StimCell Energetics Inc. (STME)

Market Cap	3.81M -30.9%
Revenue (ttm)	n/a
Net Income	-885.25K
EPS	-0.04
Shares Out	21.14M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.2021
Previous Close	0.2184
Day's Range	0.1964 - 0.2021
52-Week Range	0.1964 - 0.4800
Beta	46.85
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About StimCell Energetics

StimCell Energetics Inc., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for thr...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2010
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: STME

Financial Performance

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 20, 2026

Data Sources Report a data error